Lite Strategy, Inc. Common Stock LITS
i
Market datapartial · fetched 2026-11-13T01:27:17.501Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T22:48:20.28370156Z
FundamentalsAlpha Vantage · unavailable
Lite Strategy, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | ||||||
| 25Δ | ||||||
| 30Δ | ||||||
| 35Δ | ||||||
| 40Δ | 1.31 | 291.5% | 29.4% | |||
| 45Δ | 1.70 | 294.6% | 26.5% | |||
| 50Δ | 2.08 | 297.8% | 23.6% | |||
| 55Δ | 2.46 | 300.9% | 20.7% | |||
| 60Δ | 2.85 | 304.1% | 17.9% | |||
| 65Δ | 3.23 | 307.2% | 15.0% | |||
| 70Δ | 3.62 | 310.4% | 12.1% | |||
| 75Δ | 4.00 | 313.5% | 9.2% | |||
| 80Δ | 4.38 | 316.6% | 6.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.31
- IV
- 291.5%
- B/E move
- 29.4%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.70
- IV
- 294.6%
- B/E move
- 26.5%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.08
- IV
- 297.8%
- B/E move
- 23.6%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.46
- IV
- 300.9%
- B/E move
- 20.7%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.85
- IV
- 304.1%
- B/E move
- 17.9%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.23
- IV
- 307.2%
- B/E move
- 15.0%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.62
- IV
- 310.4%
- B/E move
- 12.1%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.00
- IV
- 313.5%
- B/E move
- 9.2%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.38
- IV
- 316.6%
- B/E move
- 6.3%
Options history
Table
| Date | IV (%) |
|---|---|
| 337.49% |
Biotechnology
LKFT
Lakefront Biotherapeutics NV (LKFT) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs in oncology and infectious diseases through…
More →LRMR
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. The company is headquartered in Bala Cynwyd,…
More →LXEO
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company is headquartered in New York, New York.
More →LXRX
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in…
More →LYEL
Lyell Immunopharma, Inc., a T-cell reprogramming company, is dedicated to the development of T-cell therapies for patients with solid tumors. The company is headquartered in South…
More →MANE
Description unavailable
More →